Cancer drug: Dr Reddy's Labs, Alvotech ink pact to codevelop biosimilar candidate to Keytruda Ruchika Sharma5 Jun 2025 10:30 AM ISTHyderabad: Dr Reddy's Laboratories Ltd. and Alvotech, a global biotech company specializing in the development and manufacture of...
Nrf2 identified as a key driver of treatment resistance in osteosarcoma: Study Dr. Kamal Kant Kohli4 Jun 2025 8:30 PM ISTA deeper understanding of osteosarcoma, the most common primary malignant bone tumor affecting children and adolescents, is reshaping strategies for...
Exercise Cuts Cancer Death Risk by Over a Third: Study Finds Dr. Bhumika Maikhuri4 Jun 2025 8:15 AM ISTIn a study published in the New England Journal of Medicine, researchers have provided the most definitive evidence to date that structured exercise...
Therapeutic Thoracentesis Adds No Benefit Over Diuretics in Acute Heart Failure with Pleural Effusion: Study Jacinthlyn Sylvia3 Jun 2025 9:00 AM ISTA new study published in the journal of Circulation found that left ventricular ejection fraction <=45%, and moderate pleural effusion, diuretics...
Age-related genetic changes in blood associated with poor cancer prognosis; Study Dr. Kamal Kant Kohli2 Jun 2025 9:00 PM ISTResearchers from the Francis Crick Institute, UCL, Gustave Roussy and Memorial Sloan Kettering Cancer Center (MSK), have discovered that expansion of...
Women with low muscle mass have worse prognosis in breast cancer treatment, reveals research Dr. Kamal Kant Kohli1 Jun 2025 9:00 PM ISTMaintaining muscle mass has proven to be crucial for patients undergoing cancer treatment. Studies have shown that individuals with more muscle tend...
Simple Hysterectomy Effective for Low-Risk Early Cervical Cancer: JAMA Medha Baranwal1 Jun 2025 8:45 PM ISTUSA: Researchers have found in a cohort study that long-term survival rates were similar between patients undergoing simple hysterectomy and those...
Alembic Pharma bags USFDA okay for blood cancer drug Bosutinib Ruchika Sharma30 May 2025 2:52 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that the company has received final approval from the US Food & Drug Administration...
AstraZeneca gets CDSCO nod for new indications of Benralizumab, Osimertinib in India Ruchika Sharma30 May 2025 1:00 PM ISTBangalore: AstraZeneca Pharma India Limited has received regulatory approval from the Central Drugs Standard Control Organisation...
AstraZeneca Imfinzi recommended for approval in EU for adults with muscle-invasive bladder cancer Ruchika Sharma29 May 2025 2:15 PM ISTCambridge: AstraZeneca has announced that Imfinzi (durvalumab) has been recommended for approval in the European Union (EU) for the...
Bayer Sevabertinib gets USFDA Priority Review status for HER2-mutant non-small cell lung cancer Ruchika Sharma29 May 2025 11:15 AM ISTBerlin: Bayer has received Priority Review status from the US Food and Drug Administration (FDA) for the investigational compound sevabertinib...
Bristol Myers Squibb bags European Commission nod for Subcutaneous formulation of Opdivo across multiple solid tumor indications Ruchika Sharma29 May 2025 10:00 AM ISTPrinceton: Bristol Myers Squibb has received approval from the European Commission (EC) for a new Opdivo (nivolumab) formulation...
